Assessment of Patient-Reported Clinical Outcome in Pancreatic and Other Hepatobiliary Cancers: The FACT Hepatobiliary Symptom Index
作者： Susan Yount , David Cella , Kimberly Webster , Nancy Heffernan , Chih-Hung Chang
DOI: 10.1016/S0885-3924(02)00422-0
关键词:
摘要: Abstract This study's aim was to develop and validate a symptom index derived from the Functional Assessment of Cancer Therapy-Hepatobiliary, questionnaire measuring general hepatobiliary disease specific aspects quality life. The item pool narrowed 26 questions that assess symptoms function. Each 95 cancer experts list 5 most important attend when treating advanced disease. Eight were endorsed by more than 20% (3 pain, 2 fatigue, nausea, weight loss, jaundice) named FACT-Hepatobiliary Symptom Index-8 (FHSI-8). Among 51 patients, FHSI-8 showed good internal consistency (0.79), test-retest reliability (r = 0.86), strong association with mood −0.56), patient differentiation ECOG Performance Status Rating ( P
jpsmjournal.com
elsevier.com参考文章(49)
Heinrich Rl, Schag Ca, Development of a comprehensive quality of life measurement tool: CARES. Oncology. ,vol. 4, pp. 135- ,(1990)
R Temple, J R Johnson, Food and Drug Administration requirements for approval of new anticancer drugs. Cancer treatment reports. ,vol. 69, pp. 1155- 1159 ,(1985)
C. S. Glover, G. A. Alexander, B. A. Miller, L. Bernstein, J. L. Young, C. R. Key, D. West, J. M. Liff, G. M. Swanson, L. N. Kolonel, Racial/ethnic patterns of cancer in the United States, 1988-1992. Racial/ethnic patterns of cancer in the United States, 1988-1992.. ,(1996)
Jenny Morris, David Perez, Bronwen McNoe, THE USE OF QUALITY OF LIFE DATA IN CLINICAL PRACTICE Quality of Life Research. ,vol. 7, pp. 85- 91 ,(1997) , 10.1023/A:1008893007068
Paul Geels, Elizabeth Eisenhauer, Andrea Bezjak, Benny Zee, Andrew Day, Palliative Effect of Chemotherapy: Objective Tumor Response Is Associated With Symptom Improvement in Patients With Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 18, pp. 2395- 2405 ,(2000) , 10.1200/JCO.2000.18.12.2395
M J Brady, D F Cella, F Mo, A E Bonomi, D S Tulsky, S R Lloyd, S Deasy, M Cobleigh, G Shiomoto, Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. Journal of Clinical Oncology. ,vol. 15, pp. 974- 986 ,(1997) , 10.1200/JCO.1997.15.3.974
Walter O. Spitzer, Annette J. Dobson, Jane Hall, Esther Chesterman, John Levi, Richard Shepherd, Renaldo N. Battista, Barry R. Catchlove, Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. Journal of Chronic Diseases. ,vol. 34, pp. 585- 597 ,(1981) , 10.1016/0021-9681(81)90058-8
H A Burris, M J Moore, J Andersen, M R Green, M L Rothenberg, M R Modiano, M C Cripps, R K Portenoy, A M Storniolo, P Tarassoff, R Nelson, F A Dorr, C D Stephens, D D Von Hoff, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of Clinical Oncology. ,vol. 15, pp. 2403- 2413 ,(1997) , 10.1200/JCO.1997.15.6.2403
M J Moore, D Osoba, K Murphy, I F Tannock, A Armitage, B Findlay, C Coppin, A Neville, P Venner, J Wilson, Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. Journal of Clinical Oncology. ,vol. 12, pp. 689- 694 ,(1994) , 10.1200/JCO.1994.12.4.689
David Andrich, Application of a psychometric rating model to ordered categories which are scored with successive integers Applied Psychological Measurement. ,vol. 2, pp. 581- 594 ,(1978) , 10.1177/014662167800200413